Contrast-Enhanced Magnetic Resonance Imaging: Why and How? | p. 1 |
Gd-DTPA Tolerance and Clinical Safety | p. 11 |
Primary Neoplasms and Postoperative/Postradiation Changes in the Brain | p. 23 |
Secondary Neoplasms and Meningeal Disease | p. 101 |
Brain Infarction | p. 147 |
CNS Infection | |
Infection in Non-Immune-Compromised Patients | p. 161 |
Infection in AIDS Patients | p. 189 |
White Matter Disease | p. 207 |
Primary Neoplasms in the Spine | p. 233 |
Non-Neoplastic Processes in the Spine | p. 267 |
Trends and New Developments in MRI Contrast Enhancement | p. 301 |
Subject Index | p. 327 |
Table of Contents provided by Blackwell. All Rights Reserved. |